Oneok (OKE) 2025 Earnings: Q4 Results and Outlook Ahead
ONEOK posted robust Q4 2025 results, boosting full-year EBITDA, trimming debt, and highlighting synergies from recent...
We compare Which Dividend Aristocrats Etf Did Best In 2024, spotlighting performance leaders and factors behind stronger returns.
23,392 articlesONEOK posted robust Q4 2025 results, boosting full-year EBITDA, trimming debt, and highlighting synergies from recent...
In February, Fluor Corp. shares kept climbing as demand for infrastructure and energy projects stayed resilient. This...
Two midstream ETFs compete on tax structure and cash-flow strategy. A closer look at AMLP and MLPX reveals how holdin...
Turning 65 is a milestone, but it also opens a maze of Medicare decisions. This article reveals a Medicare mistake co...
Federal regulators weigh possible actions after new allegations that polymarket allegedly faked trades. The case test...
Colorado regulators announced a settlement with Unlock Technologies to reclassify home equity agreements as consumer ...
Abbott Laboratories and Pfizer both delivered solid Q1 2026 numbers, yet the market sentiment diverged. Abbott slumpe...
Institutional money flows into Bitcoin and Ethereum spur a new wave of adoption, while Solana, XRP, and Chainlink gro...
On Feb 18, KVUE defied expectations with a stronger quarter, lifting the stock even as the market edged higher. Here’...
Anthropic’s spacex compute deal expands access to the Colossus supercomputer, boosting Claude capacity while triggeri...
In March 2026, traders rethink brokers as crypto access and extended hours rise. Here are the top moomoo alternatives...
When a single security gap triggers a major depeg, everyday investors feel the impact first. This article unpacks res...